Trisenox and febrile neutropenia 
Trisenox and febrile neutropenia Patient Reports February 13, 2012
Trisenox Side Effects Report #4855377-X
Trisenox side effect was reported by a Physician from UNITED STATES on Sept 08, 2005. Male patient, 57 years of age, weighting 134.0 lb, was diagnosed with myeloid leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia. Trisenox dosage: 15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 10/01/2005.
Trisenox Side Effects Report #4597936-8
Trisenox side effect was reported by a Physician from on Feb 09, 2005. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, fluid overload, mental status changes, pneumonia
, renal failure acute, respiratory distress. Trisenox dosage: unknown. During the same period patient was treated with CYTOSINE ARABINOSIDE. Patient was hospitalized. Patient died on 10/28/2003.Trisenox Side Effects Report #5853383-X
Trisenox side effect was reported by a Physician from ITALY on Oct 26, 2006. Female patient, 74 years of age, weighting 121.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia, mucosal inflammation. Trisenox dosage: 13.5 MG 13.5 MG 2 TIMES/WEEK INTRAVENOUS DRIP. During the same period patient was treated with ASCORBIC ACID, PANTECTA. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #4687390-X
Trisenox side effect was reported by a Physician from on May 20, 2005. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome, neutropenia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: anaemia, chills, disease progression, dyspnoea exertional, febrile neutropenia, myelodysplastic syndrome, oral candidiasis, pain in extremity, productive cough. Trisenox dosage: unknown. During the same period patient was treated with VITAMIN D, FILGRASTIM. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5491898-7
Trisenox side effect was reported by a Health Professional from UNITED STATES on Oct 11, 2007. Male patient, 70 years of age, weighting 200.6 lb, was diagnosed with multiple myeloma
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute respiratory failure, atelectasis, febrile neutropenia, pleural effusion. Trisenox dosage: 0.25 MG/KG INTRAVENOUS. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5515367-0
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 25, 2007. Female patient, weighting 142.0 lb, was diagnosed with multiple myeloma
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: bacteraemia, blood magnesium increased, coronary artery disease , enterococcal infection, febrile neutropenia, haematocrit decreased, haemoglobin decreased, heart rate increased, hypotension. Trisenox dosage: 0.25 MG/KG UNK INTRAVENOUS. During the same period patient was treated with HYDROMORPHONE, LOPERAMIDE, HEPARIN, CHLORIDE, LANOLIN, LORAZEPAM, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #5320873-8
Trisenox side effect was reported by a Physician from JAPAN on Apr 23, 2007. Male patient, 79 years of age, was diagnosed with acute promyelocytic leukaemia, arrhythmia
and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, electrocardiogram qt prolonged, facial palsy, febrile neutropenia, herpes zoster, liver disorder, rash . Trisenox dosage: 8.0625 MG DAILY. During the same period patient was treated with DISOPYRAMIDE PHOSPHATE, MEXILETINE HYDROCHLORIDE, NIFEDIPINE, HALOXAZOLAM, ZOLPIDEM TARTRATE. Patient was hospitalized and became disabled. Patient recovered.Trisenox Side Effects Report #5233587-X
Trisenox side effect was reported by a Physician from JAPAN on Jan 23, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5248064-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 07, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5257757-X
Trisenox side effect was reported by a Physician from JAPAN on Feb 15, 2007. Female patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, febrile neutropenia, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, protein total decreased. Trisenox dosage: 7.95 MG QD INTRAVENOUS DRIP. Patient recovered.
Trisenox Side Effects Report #5306139-0
Trisenox side effect was reported by a Physician from JAPAN on Apr 02, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE. Patient died on 01/19/2006.
Trisenox Side Effects Report #5393083-6
Trisenox side effect was reported by a Physician from JAPAN on June 27, 2007. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cardio-respiratory arrest, electrocardiogram qt prolonged, febrile neutropenia, gamma-glutamyltransferase increased, hyperglycaemia, staphylococcal sepsis. Trisenox dosage: 9.69 MG QD INTRAVENOUS DRIP. During the same period patient was treated with DALTEPARIN, QUETIAPINE FUMARATE, VANCOMYCIN HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE, METHYLPHENIDATE, PAROXETINE HYDROCHLORIDE HYDRATE. Patient died on 01/19/2006.
Trisenox Side Effects Report #5179504-2
Trisenox side effect was reported by a Physician from JAPAN on Nov 30, 2006. Male patient, 58 years of age, weighting 132.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood bilirubin increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, fungal infection
, hepatic function abnormal, hypercalcaemia. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE, VORICONAZOLE, SULFAMETHOXAZOLE W. Patient was hospitalized. Patient died on 05/16/2006.Trisenox Side Effects Report #5197209-9
Trisenox side effect was reported by a Physician from JAPAN on Dec 12, 2006. Male patient, 58 years of age, weighting 132.3 lb, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, fungal infection
, hypercalcaemia, hyperglycaemia, hyponatraemia, oliguria. Trisenox dosage: 9 MG QD INTRAVENOUS DRIP. During the same period patient was treated with GABEXATE MESILATE, DANAPAROID, FUROSEMIDE, VORICONAZOLE, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 05/16/2006.Trisenox Side Effects Report #6084441-5
Trisenox side effect was reported by a Physician from JAPAN on Feb 05, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, febrile neutropenia, leukocytosis, pleural effusion, renal impairment, respiratory disorder, sepsis
, septic shock. Trisenox dosage: 11 MG QD INTRAVENOUS DRIP. Patient died on 01/30/2009.Trisenox Side Effects Report #6106670-4
Trisenox side effect was reported by a Physician from JAPAN on Feb 17, 2009. Male patient, 46 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute promyelocytic leukaemia differentiation syndrome, electrocardiogram qt prolonged, febrile neutropenia, leukocytosis, neutrophil count decreased, pleural effusion, renal impairment, respiratory disorder, septic shock. Trisenox dosage: 11 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, IDARUBICIN HYDROCHLORIDE, ITRACONAZOLE, POTASSIUM CHLORIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SENNOSIDE. Patient died on 01/30/2009.
Trisenox Side Effects Report #5062550-7
Trisenox side effect was reported by a Physician from JAPAN on July 07, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5030964-7
Trisenox side effect was reported by a Physician from JAPAN on June 05, 2006. Male patient, 34 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: febrile neutropenia, leukopenia. Trisenox dosage: 14.55 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IDARUBICIN, DANAPAROID, LAFUTIDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5084862-3
Trisenox side effect was reported by a Physician from JAPAN on Aug 01, 2006. Male patient, 30 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, electrocardiogram qt prolonged, febrile neutropenia, white blood cell count decreased. Trisenox dosage: 8.43 MG QD INTRAVENOUS DRIP. During the same period patient was treated with IMIPENEM CILASTATIN, BIFIDOBACTERIUM, LOPERAMIDE HYDROCHLORIDE, CEFEPIME DIHYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Trisenox Side Effects Report #5142589-3
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 12, 2006. Female patient, 24 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: depressed level of consciousness, encephalopathy, eye rolling, febrile neutropenia, head titubation, movement disorder
, pancreatitis, somnolence, urine arsenic increased. Trisenox dosage: unknown. Patient was hospitalized. Patient recovered.Trisenox Side Effects Report #4831846-3
Trisenox side effect was reported by a Physician from UNITED STATES on Oct 31, 2005. Male patient, 57 years of age, weighting 134.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Trisenox. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, febrile neutropenia, malignant neoplasm progression. Trisenox dosage: 15 MG QD INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient died on 10/01/2005.